Stocks · Health care · Pharmaceutical Preparations

Generate Biomedicines, Inc.

GENB

United States Fiscal year ends December CIK 0002100782

14.34

+2.50%

Close, 9 Oct 2026 · USD

Alert on the numbers Alert on insider trades

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

14.34 on 9 Oct 2026

5 buys0 sales at will1 planned sale

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
1 Sep 2026	ARNOLD FRANCES Director	Sold on a plan	$16.00K	0.4%
4 Mar 2026	Nally Michael Chief Executive Officer	Bought	$240.00K	3.6%
2 Mar 2026	AFEYAN NOUBAR Director	Bought	$150.00M	159%
2 Mar 2026	Silvers Jason President & CFO	Bought	$32.00K	opened
2 Mar 2026	Mendillo Jane L Director	Bought	$24.00K	opened
2 Mar 2026	Grous Beth Chief People Officer	Bought	$4.80K	opened